Results 1 to 10 of about 5,587,889 (314)

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024.

open access: yesDiabetes Care, 2023
The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate
Nuha A. ElSayed   +22 more
semanticscholar   +1 more source

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021.

open access: yesDiabetes Care, 2020
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to ...

semanticscholar   +1 more source

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022.

open access: yesDiabetes Care, 2021
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to ...
B. Draznin   +17 more
semanticscholar   +1 more source

The paradox between resistance to hypoxia and liability to hypoxic damage in hyperglycemic peripheral nerves. Evidence for glycolysis involvement [PDF]

open access: yes, 1993
Isolated ventral and dorsal rat spinal roots incubated in normal (2.5 mM) or high glucose (25 mM) concentrations or in high concentrations of other hexoses were exposed transiently to hypoxia (30 min) in a solution of low buffering power.
Grafe, Peter   +2 more
core   +1 more source

2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.

open access: yesDiabetes Care, 2022
The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate
Nuha A. ElSayed   +19 more
semanticscholar   +1 more source

Epidemiology and immunogenetic background of islet cell antibody - positive nondiabetic schoolchildren : Ulm-Frankfurt population study [PDF]

open access: yes, 1991
Islet cell antibodies (ICAs) were determined in a large cohort of white nondiabetic schoolchildren (n = 4287) from a homogenous population in southern Germany.
Böhm, Bernhard Otto   +9 more
core   +1 more source

Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome [PDF]

open access: yes, 1993
Cytoplasmic islet cell antibodies are well-established predictive markers of IDDM. Although target molecules of ICA have been suggested to be gangliosides, human monoclonal ICA of the immunoglobulin G class (MICA 1-6) produced from a patient with newly ...
Meinck, Hans-Michael   +5 more
core   +1 more source

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

open access: yesNew England Journal of Medicine, 2016
BACKGROUND The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown.
S. Marso   +14 more
semanticscholar   +1 more source

Deaths attributable to diabetes in the United States: comparison of data sources and estimation approaches [PDF]

open access: yes, 2017
OBJECTIVE: The goal of this research was to identify the fraction of deaths attributable to diabetes in the United States. RESEARCH DESIGN AND METHODS: We estimated population attributable fractions (PAF) for cohorts aged 30±84 who were surveyed in the ...
Preston, Samuel, Stokes, Andrew
core   +9 more sources

The Sulfonylurea Drug, Glimepiride, Stimulates Glucose Transport, Glucose Transporter Translocation, and Dephosphorylation In Insulin-Resistant Rat Adipocytes In Vitro [PDF]

open access: yes, 1993
Sulfonylurea drugs are widely used in the therapy of NIDDM. The improvement of glucose tolerance after long-term treatment of NIDDM patients with the drug can be explained by stimulation of glucose utilization in peripheral tissues that are characterized
Müller, Günter, Wied, Susanne
core   +1 more source

Home - About - Disclaimer - Privacy